Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

French ophthalmology groups fight back against insurers

Medic’oeil, an ophthalmology chain based in Eastern France, is trying to create a national network of eye doctors. Owned by the Helvetian Eye Centre, Medic’oeil aims to develop 87 centres in six years. We speak to Arnaud Mathaly, president of Helvetian Eye Centre, about the model. But consolidating outpatient in France is tough. Figaro reports that Dentexia, a low costdental chain, may be about to go bust.
March 10, 2016

Bupa smiles despite write offs

What looks at first sight like dismal results from Bupa, the international insurer and healthcare operator, with a fall in pre-tax profits of 39% to £374m on sales of £9.8bn is actually much brighter than they first appear. Exclude most write offs and currency fluctuations, and pre-tax profits fell 2%, exclude all write offs and they rose 7% on sales up 6% in constant currencies. That is despite a 5% drop in sales at Bupa Global, the international insurance arm as Bupa dropped unprofitable business. We talk to CEO Stuart Fletcher about how apps and ehealth are helping sales, new insurance offers and acquisitions.
March 3, 2016

Meinian looks beyond iKang

Chinese outpatient and health check-up group, Meinian Onehealth, has purchased a controlling stake in rival, Ciming Health. Meinian is paying 2.7bn Yuan (US$413m) for 72.22% and will raise 1.9bn Yuan (US$291m) worth of funding through a private placement. The deal suggests Meinian has given up on the takeover of rival, iKang, which is currently pursuing a lawsuit for information theft.
March 2, 2016

Solid Nordic results suggest more IPOs

Nordic healthcare groups Capio, Attendo and Pihlajalinna have released solid annual results after floating in 2015. Political risk appears to be fading in Sweden and new public-private opportunities are under way in Finland. Could rivals like Ambea and Humana file for IPOs in 2016? We look at the figures.
March 2, 2016

Dr Agarwal bets on Africa

Of all types of Indian healthcare operators none have been as successful in Africa as Dr Agarwal, India’s second largest eye care chain. In just five years, it has grown its African business from nothing to 30-35% of sales. So far, it has 15 clinics in Mozambique, Nigeria, Madagascar, Rwanda, Uganda, Zambia, the Seychelles and Mauritius, but it plans to open six this year and to have 40 by 2020. We talk to Dr Agarwal’s CEO S. Rajagopalan.
February 29, 2016

TVM seeks a dozen investments for new fund

TVM Capital Healthcare is to raise a third growth capital fund to invest in a dozen healthcare services, medtech and pharma companies. With a target of $300m, the new fund is six times larger than the first $50m fund raised in 2010, which was invested in five Middle East healthcare service groups and an Egyptian medtech player. The sole sale from that round has already netted $50m for TVM. So what is CEO Helmut Schuehsler looking for this time round?
February 25, 2016

Regina Maria and Medlife in M&A race to build national chains

Regina Maria, the second largest Romanian hospital operator, which was bought by Mid Europa in 2015, has lined up several deals. It, and Medlife, the number one player, will be racing to build comprehensive national coverage over the next few years. Medlife has just announced a syndicated loan of €56m of which €20m plus €5m from medlife will be allocated for acquisitions.
February 25, 2016

Consolidating Ukraine

Into-sana, the largest hospital group in Odessa and possibly the largest in Ukraine, has recently bought two outpatient clinics in Kiev. Konstantin Lebediev, a medtech healthcare services consultant based in Denmark, suggests this is the start of a national chain.
February 22, 2016

Rx Health Management builds US$200m fund

The former Egyptian health minister, Dr Hatem Elgabaly, hopes to raise US$200m to invest in African healthcare by the middle of 2017. Three deals in Egypt and Nigeria are under negotiation and three others in Morocco and Nigeria are early-stage. All are already funded, he claims. The strategy is to build a platform in hospitals, diagnostics and pharma in North Africa and replicate their success in Sub-Saharan Africa by consolidating and modernising mum'n'pops or expanding existing platforms.
February 22, 2016
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us